Blank check company Bold Eagle Acquisition filed for a $250 million initial public offering on Friday with the Securities and Exchange Commission.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Merit Medical Systems (MMSI – Research ...

Ginkgo Bioworks is pivoting: Once a synthetic biology darling, the flailing company has now turned to AI-driven protein ...

Amid layoffs and a disintegrating share price, former investor darling Ginkgo Bioworks is trying out a new tack to find ...

A roundup of the most newsworthy tech announcements from PR Newswire this week, including Starlink Wi-Fi on United flights ...

Brendan Smith, an analyst from TD Cowen, maintained the Buy rating on Ginkgo Bioworks Holdings (DNA – Research Report). The associated ...

By providing a ready platform for cell engineering, Ginkgo is becoming a key service provider in the biotech industry, going beyond the pharmaceutical industry and into agriculture, biosecurity, and ...

“These are scams,” said Kenny Biddle, the chief investigator for the Center of Inquiry, an organization devoted to defending ...

Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares continue to trade higher after rising nearly 10% on Tuesday. Here's a look at ...

Ginkgo Bioworks Holdings Inc (DNA) stock saw a modest uptick, ending the day at $6.81 which represents a slight increase of $0.58 or 9.31% from the prior close of $6.23. The stock opened at $6.37 and ...

Venturi Cardiology, a leading, state of the art cardiology clinic in North West England offering rapid access to clinical ...